Pompe Disease. Family Education Booklet. Division of Pediatric Genetics Metabolism and Genomic Medicine

Similar documents
Understanding Late-Onset Pompe Disease

Pompe. Lysosomal Disorders. Introduction

DEVELOPING A FOLLOW-UP FRAMEWORK FOR POMPE DISEASE

Fatty Acid Oxidation Disorders

Disorder name: Severe Combined Immunodeficiency Acronym: SCID

Fatty Acid Oxidation Disorders

Disorder name: Argininemia / Arginase deficiency Acronym: ARG 1 deficiency

Fatty Acid Oxidation Disorders Organic Acid Disorders

Amino Acid Disorders. Disorder name: Tyrosinemia, type 1. What is tyrosinemia 1? Genetic Fact Sheets for Parents

Organic Acid Disorders

Amino Acid Disorders. What is ASAL deficiency? Genetic Fact Sheets for Parents

Organic Acid Disorders

There are four different forms of Tarui disease, which are classed by their signs and symptoms and age of presentation.

Organic Acid Disorders

A Guide for Understanding Genetics and Health

Cystic Fibrosis. Information for Caregivers

A Guide for Understanding Genetics and Health

Fever Management and Medication Dosing

Spinal Muscular Atrophy: Case Study. Spinal muscular atrophy (SMA) is a fairly common genetic disorder, affecting

Cystic Fibrosis Carrier Testing

A Guide for Understanding Genetics and Health

Organic Acid Disorders

A Guide for Understanding Genetics and Health

Heart Failure Overview

Thalassaemia. What is thalassaemia? What causes thalassaemia? What are the different types of thalassaemia?

PATIENT EDUCATION. Cystic Fibrosis Carrier Testing

Coronary Artery Disease

Cerebral Palsy. By:Carrie Siders and Kelsey Hampsey. 3rd hour.

LSD WORKSHOP WHAT EVERY PEDIATRICIAN SHOULD KNOW. Amal Al Tenaiji Pediatric Metabolic Genetics SKMC Abu Dhabi

A Guide for Understanding Genetics and Health

Congenital hypothyroidism and your child

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

Electroconvulsive Therapy (ECT)

A Guide for Understanding Genetics and Health

A Guide for Understanding Genetics and Health

Craniofacial Microsomia

immunodeficiency (ADA-SCID)

Inheritance of Gaucher Disease

What s New in Newborn Screening?

What s New in Newborn Screening?

BLINCYTO can eliminate detectable traces of cancer 1

A Guide to Genetics and Health

Information leaflet for Patients and families Germline Mosaicism

Carnitine palmitoyl transferase 2 deficiency (CPT2) is a rare inherited disorder that occurs when

I MAY NOT HAVE ALL THE ANSWERS BUT AT LEAST I HAVE THE QUESTIONS TO GET THE PROPER. care guidelines

Nemaline (rod) myopathies

Medication Policy Manual. Topic: Lumizyme, alglucosidase alfa Date of Origin: February 17, 2015

My joints ache. What is the difference between osteoporosis and osteoarthritis?

offers the possibility of a longer life 1 BLINCYTO A guide for patients and caregivers

Health Care Information for Families of Children with Down Syndrome

Randy J. EMPLICITI patient Ready to get started

Guide to Cardiology Care at Scripps

MOLECULAR DIAGNOSIS for X-LINKED INTELLECTUAL DISABILITY

was proven to help people live longer1 BLINCYTO A guide for patients and caregivers

Klinefelter syndrome ( 47, XXY )

Information for patients and families

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help

Understanding your child s heart. Coarctation of the aorta

Testing for Genetic Disorders that Cause Brain Damage

Tracheoesophageal Fistula and Esophageal Atresia

X-linked Genetic Disorders

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

ROBERTSONIAN TRANSLOCATIONS

(sunitinib malate) for Kidney Cancer

Heart Disease. Signs and Symptoms

Genetics. by their offspring. The study of the inheritance of traits is called.

Information for fathers invited for a screening test for sickle cell disease and thalassaemia major

Myotubular (centronuclear) myopathy

Karyotype = a test to identify and evaluate the size, shape, and number of chromosomes in a sample of body cells.

TEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647

A Guide to Genetics and Health

Medication Guide Clonazepam Tablets USP (kloe-na-za-pam)

A Genetic Overview of Hypophosphatasia

VALPROATE. (Epilim, Depakote ) Patient Information Booklet

Rev. date Kaiser Foundation Health Plan of Washington

DECISION QUALITY WORKSHEET TREATMENTS FOR DEPRESSION

DNA Day Illinois 2013 Webinar: Newborn Screening and Family Health History. Tuesday, April 16, 2013

Clinical Summaries. CLN1 Disease, infantile onset and others

TEMPLE. Tools Enabling Metabolic Parents LEarning ADAPTED BY THE DIETITIANS GROUP. British Inherited Metabolic Diseases Group

UNDERSTANDING GLYCOGEN STORAGE DISEASE

How are unresolved Myasthenia Gravis symptoms disrupting your day? Talk to your doctor about your symptoms

Table of Contents. Contents Page

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

Disorder name: Congenital Adrenal Hyperplasia Acronym: CAH

Genetics. the of an organism. The traits of that organism can then be passed on to, on

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug?

Diabetes and You. A Quick Guide

What is the most important information I should know about carbamazepine tablets or chewable tablets?

PKU, KUVAN, and You PKU treatment and support for adults and young adults

Patient Information Entecavir Tablets (en-tek-ah-veer)

Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate

Carrying Beta Thalassaemia A carrier can use this booklet to

Each person has a unique set of characteristics, such as eye colour, height and blood group.

Evaluation for Epilepsy Surgery

New Health Dangers from Lead

Newborn Screening for Lysosomal Storage Diseases in Missouri. Outline

Blood Glucose/Sugar Monitoring

Information leaflet for families with a history of bowel cancer or polyps. MYH Polyposis

Having memory problems? Trouble thinking clearly? If this sounds like you, or someone you know, please consider the ENGAGE Study. Patient Information

Intermediate or juvenile cystinosis is a less serious form of the disease. It may not be diagnosed until a person is a teenager.

Transcription:

Pompe Disease Family Education Booklet Division of Pediatric Genetics Metabolism and Genomic Medicine

Table of Contents What is Pompe disease?... 1 How common is Pompe disease?... 1 Basic genetic concepts... 2 What causes Pompe disease?... 3-5 How is Pompe disease inherited?... 6 What are the different forms of Pompe disease?... 7-9 Infantile-onset Pompe disease (IOPD)... 7-8 Late-onset Pompe disease (LOPD)... 9 How is Pompe disease diagnosed?... 10-11 Tests Before and During Pregnancy... 10 Newborn Screening... 10 Enzyme Testing... 11 Genetic Testing... 11 Tests During Childhood and Adulthood... 11 Is there a cure?... 12 What is Enzyme Replacement Therapy (ERT)?... 12-13 What is the follow-up and disease management plan?... 14 Infantile-onset Pompe disease:... 14 Late-onset Pompe disease:... 14 What else should I know about Pompe disease diagnosis?... 15 CRIM Status... 15 Pseudodeficiency... 15 Where can I find more information about clinical trials?... 16 Where can I find more information about Pompe disease?... 16

What is Pompe disease? Pompe disease is a genetic disorder that leads to problems with breaking down glycogen. Glycogen is a type of sugar that is stored in our cells. Another name for Pompe disease is Glycogen Storage Disease Type II (GSD II). Pompe disease is part of a group of diseases called lysosomal storage disorders (LSDs). Pompe disease is divided into two groups based the age when symptoms started and how severe they are. The two types of the disease are: 1. Infantile-onset Pompe disease (IOPD) when the disease appears within a few months of birth 2. Late-onset Pompe disease (LOPD) when the disease appears later in childhood, adolescence, or adulthood. How common is Pompe disease? In the United States, about 1 in 40,000 people have Pompe disease but it is much more common among African Americans. It is estimated that 1 in 14,000 African Americans have Pompe disease. -1-

Basic Genetic Concepts In order to understand the cause of Pompe disease, it is important to understand some basic genetic concepts. The human body is made up of many cells, each cell contains 23 pairs of chromosomes (or 46 altogether). One chromosome from each pair comes from mom and one from dad. Chromosomes carry our genes. Genes are like the instruction book for the body. They tell the body how to grow and function. DNA (Deoxyribonucleic acid) are like the letters in the instruction book. Genes are pieces of DNA that explain how to make many types of chemicals, which are used to make sure the body works properly. One type of chemical is called an enzyme. Enzymes help with reactions, such as breaking glycogen (a type of stored sugar). -2-

What causes Pompe Disease? Pompe disease occurs when a gene called the GAA gene is not working properly. This nonworking gene prevents the cells from making enough of an enzyme called acid alpha glucosidase. -3-

There are structures in the cell called lysosomes. Lysosomes are the recycling centers of the cell. One of their jobs is to break down glycogen. Normally, an enzyme called acid alpha glucosidase is used tobreak down the glycogen in the lysosome (pictured below). -4-

If the cells do not make enough acid alpha glucosidase and are not able to break down the glycogen, then glycogen builds up the lysosome. The buildup causes damage to the body, particularly to the heart and muscles. -5-

How is Pompe disease inherited? Pompe disease is a genetic condition. A person affected with the disease inherits two nonworking genes one from each parent. This is called autosomal recessive inheritance. When a child has Pompe disease, it means that both parents are carriers of a nonworking gene. Each parent has one working copy of the gene and one nonworking copy of the gene. The nonworking copy cannot properly produce the enzyme needed to break down glycogen. Since they still have one normal working copy, the parents do not show symptoms of the disease. Being a carrier does not cause health problems. When both parents are carriers, there is a 1 in 4 (25%) chance of having a child with Pompe disease. This is true for each pregnancy. -6-

What are the different forms of Pompe disease? Infantile-onset Pompe disease (IOPD) This form of Pompe disease begins within the first few months of life. Babies usually show signs of muscle weakness and have heart problems. Without treatment, this form of Pompe disease can lead to death within the first year of life. Children with this form of Pompe disease have normal intelligence. Medical problems of infantile-onset Pompe disease Weak sucking and swallowing muscles can make eating difficult. This can lead to problems gaining weight. Overall muscle weakness and poor muscle tone. This can cause a floppy appearance and problems with movement. -7-

Weak breathing muscles can cause difficulty breathing. The weakness also increases risk for infections. These muscles are located below and near the ribs (diaphragm). Heart problems Babies usually have larger hearts (cardiomegaly) and thicker heart muscle (cardiomyopathy). These heart problems can cause heart failure. -8-

Late-onset Pompe disease (LOPD) The late-onset type form of Pompe disease can begin anytime from around the age of 1 year old through adulthood. It is less severe because there are usually no heart problems. Symptoms include increased muscle weakness, especially in the legs, and breathing problems. People with this form of Pompe disease have normal intelligence. Medical problems of late-onset Pompe disease Eating difficulties Weak jaw and swallowing muscles can make eating difficult. This can lead to trouble gaining or maintaining weight. Muscle weakness Gradual weakening of leg and hip muscles can cause walking difficulties and possible need for support. Breathing concerns Weakness of the muscles needed to breathe can cause difficulty breathing, higher risk for infections, low energy and sleep difficulties. -9-

How is Pompe Disease diagnosed? It is very important to diagnose Pompe disease early to begin treatment. Early treatment is critical to delay some of the permanent damage caused by the disease. Tests Before and During Pregnancy It is possible to have tests before or during a pregnancy to find out if the baby is affected. Testing for Pompe can be done before pregnancy by a process called preimplantation genetic testing. Testing while pregnant (prenatal testing) can be done using a tissue sample taken from the placenta or from the fluid that surrounds the unborn baby (amniotic fluid). Prenatal testing can be performed as early as the 10th week of pregnancy. Decisions about prenatal testing are personal and can be complicated. It can be helpful to speak to a genetic counselor or physician to learn more about these options and discuss what is best for your family. Newborn Screening Newborn screening (NBS) is the process of testing newborn babies for some serious, but treatable, conditions. Newborn screening involves a heel prick for blood testing. For Pompe disease, a positive newborn screen alone does not mean the baby has the disease. Further testing is needed in order to diagnose Pompe disease. Each state decides which diseases and conditions to test for in their Newborn screening program. To find out if your state is screening for Pompe disease, you can visit: http://www.newsteps.org/pompe. -10-

Enzyme Testing In order to make a Pompe disease diagnosis, your doctor measures the acid alpha glucosidase enzyme activity. Usually activity is measured by taking a small amount of blood, however, skin and muscle can also be used. People with Pompe disease will show low levels of acid alpha glucosidase enzyme activity. Genetic Testing Genetic testing is also important for diagnosing Pompe disease. Your doctor will test for the GAA gene, the only gene that causes Pompe disease. The testing includes a small blood sample and looks for changes or missing pieces of the gene to help confirm Pompe disease. In addition, once your doctor knows the exact change in the GAA gene, they can test other family members who may be at risk for Pompe disease. Tests During Childhood and Adulthood Doctors may test for late-onset type of Pompe disease when signs and symptoms of the disease are not explained by other causes. These signs include things like muscle weakness and breathing problems. In order to diagnose Pompe disease, the doctor will order a blood test that measures the enzyme activity of acid alpha glucosidase. -11-

Is there a cure? At this time, there is no cure for Pompe disease. However, there are ways to treat and manage the disease. Enzyme replacement therapy (ERT) is a treatment that can help with the breakdown of glycogen. Research is currently being done to improve treatment options for Pompe disease. What is Enzyme Replacement Therapy (ERT)? There is no cure for Pompe disease. However, the best treatment option is Enzyme Replacement Therapy (ERT). ERT is a medical treatment that replaces the missing enzyme, acid alpha glucosidase, in patients with Pompe disease. A drug called Lumizyme was approved by the Food and Drug Administration (FDA) to treat all types of Pompe disease. Lumizyme is an artificial version of acid alpha glucosidase enzyme. ERT is given to patients by a slow intravenous infusion (IV). Your doctor will calculate the dose according to your child s weight and they will receive treatment every two weeks. ERT improves muscle weakness, heart muscle, motor skills and breathing problems. Your child should start ERT as soon as the diagnosis of Pompe disease is confirmed. It cannot repair muscle or heart damage that has already occurred but it can help reduce further damage. -12-

How ERT works within the cell: -13-

What is the follow-up and disease management plan? Children with Infantile-onset Pompe disease will have: Regular heart evaluations including echocardiogram (sound wave test) and electrocardiogram (electrical tracing of the heartbeat) Evaluation of muscle tone and skeletal problems Evaluation of development, growth and overall status twice per year Physical therapy and occupational therapy as needed Regular nutrition and food assessment and support Breathing assessment and support including: o sleep evaluation o lung function tests or surgery to make an airway in the windpipe (tracheostomy) for those having breathing difficulty Kidney tests Hearing test Children with late onset Pompe disease will have: Physical therapy and occupational therapy for muscle weakness Hearing test Heart tests including echocardiogram and electrocardiogram Monitoring of overall muscle and bone status Breathing tests (sleep test if needed) Physical examination Kidney tests -14-

What else should I know about Pompe disease diagnosis? CRIM Status CRIM stands for Cross-Reactive Immunologic Material. Before ever receiving treatment for infantile Pompe disease, your doctor must test your CRIM status using a blood or skin sample. When a patient makes some of their own acid alpha glucosidase enzyme, they are CRIM positive. When they do not make any of their own enzyme, they are CRIM negative. About 66 out of 100 people with infantile Pompe disease make a small amount of acid alpha glucosidase. However, 33 out of 100 patients do not make any acid alpha glucosidase. People with late-onset Pompe disease are CRIM positive. Your doctor must know your CRIM status because it will help to direct treatment. When a person is CRIM negative, they need extra medicine to help protect their immune system. Pseudodeficiency Pseudodeficiency ( pseudo means false or misleading ) occurs when you have low enzyme activity when they test your blood in the laboratory. It happens when there is a specific type of change on both copies of the GAA gene. These changes do not cause you to have symptoms of Pompe disease. This condition does not cause health problems but it can be stressful for families by causing false positive results. This means that the testing shows low acid alpha glucosidase enzyme levels but you do not actually develop Pompe disease. The prevalence of pseudodeficiency in the United States is less than 1 person out of 100. -15-

Where can I find more information about research on Pompe disease? For information on clinical trials, visit http://www.clinicaltrials.gov and search Pompe disease. Where can I find more information about Pompe disease? Pompe Community (information provided by Genzyme Therapeutics) o http://www.pompe.com Acid Maltase Deficiency Association (AMDA) o http://www.amda-pompe.org Association for Glycogen Storage Disease o http://www.agsdus.org/type-ii.php Association for Glycogen Storage Disorders UK o http://www.agsd.org.uk/tabid/1134/default.aspx National Organization of Rare Diseases or NORD o http://rarediseases.org/rare-diseases/pompe-disease/ Genetics Home Reference Pompe disease o https://ghr.nlm.nih.gov/condition/pompe-disease Baby s First Test o http://www.babysfirsttest.org/newborn-screening/conditions/pompe Disclaimer: This document contains information and/or instructional materials developed by Michigan Medicine for the typical patient with your condition. It may include links to online content that was not created by Michigan Medicine and for which Michigan Medicine does not assume responsibility. It does not replace medical advice from your health care provider because your experience may differ from that of the typical patient. Talk to your health care provider if you have any questions about this document, your condition or your treatment plan. Authors: Rachel Fisher, MS, CGC, Jamie Love-Nichols, BS Reviewers: Dr. Ayesha Ahmad, MD, Karelyn Munro, BA, Ruti Volk, MSI, AHIP Patient Education by Michigan Medicine is licensed under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 Unported License. Last Revised 08/2017-16-